ID   NECT1_HUMAN             Reviewed;         517 AA.
AC   Q15223; O75465; Q2M3D3; Q9HBE6; Q9HBW2;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   26-SEP-2001, sequence version 3.
DT   03-AUG-2022, entry version 203.
DE   RecName: Full=Nectin-1;
DE   AltName: Full=Herpes virus entry mediator C;
DE            Short=Herpesvirus entry mediator C;
DE            Short=HveC;
DE   AltName: Full=Herpesvirus Ig-like receptor;
DE            Short=HIgR;
DE   AltName: Full=Nectin cell adhesion molecule 1 {ECO:0000312|HGNC:HGNC:9706};
DE   AltName: Full=Poliovirus receptor-related protein 1;
DE   AltName: CD_antigen=CD111;
DE   Flags: Precursor;
GN   Name=NECTIN1 {ECO:0000312|HGNC:HGNC:9706}; Synonyms=HVEC, PRR1, PVRL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM DELTA), AND FUNCTION AS A RECEPTOR FOR
RP   HHV-1; HHV-2 AND PRV.
RX   PubMed=7721102; DOI=10.1016/0378-1119(94)00842-g;
RA   Lopez M., Eberle F., Mattei M.-G., Gabert J., Bardin F., Maroc C.,
RA   Dubreuil P.;
RT   "cDNA characterization and chromosomal localization of a gene related to
RT   the poliovirus receptor gene.";
RL   Gene 155:261-265(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM DELTA).
RX   PubMed=9616127; DOI=10.1126/science.280.5369.1618;
RA   Geraghty R.J., Krummenacher C., Cohen G.H., Eisenberg R.J., Spear P.G.;
RT   "Entry of alphaherpesviruses mediated by poliovirus receptor-related
RT   protein 1 and poliovirus receptor.";
RL   Science 280:1618-1620(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM GAMMA).
RX   PubMed=11356977; DOI=10.1128/jvi.75.12.5684-5691.2001;
RA   Lopez M., Cocchi F., Avitabile E., Leclerc A., Adelaide J.,
RA   Campadelli-Fjume G., Dubreuil P.;
RT   "Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1
RT   (or prr1-HIgR-Hvec) modulates positively and negatively susceptibility to
RT   hsv infection.";
RL   J. Virol. 75:5684-5691(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM DELTA).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 28-517 (ISOFORMS ALPHA AND DELTA),
RP   INVOLVEMENT IN EDMI, AND INVOLVEMENT IN OFC7.
RX   PubMed=10932188; DOI=10.1038/78119;
RA   Suzuki K., Hu D., Bustos T., Zlotogora J., Richieri-Costa A., Helms J.A.,
RA   Spritz R.A.;
RT   "Mutations of PVRL1, encoding a cell-cell adhesion molecule/herpesvirus
RT   receptor, in cleft lip/palate-ectodermal dysplasia.";
RL   Nat. Genet. 25:427-430(2000).
RN   [6]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HERPES SIMPLEX VIRUS
RP   1/HHV-1 AND HERPES SIMPLEX VIRUS 2/HHV-2 GLYCOPROTEIN D.
RX   PubMed=9696799; DOI=10.1128/jvi.72.9.7064-7074.1998;
RA   Krummenacher C., Nicola A.V., Whitbeck J.C., Lou H., Hou W., Lambris J.D.,
RA   Geraghty R.J., Spear P.G., Cohen G.H., Eisenberg R.J.;
RT   "Herpes simplex virus glycoprotein D can bind to poliovirus receptor-
RT   related protein 1 or herpesvirus entry mediator, two structurally unrelated
RT   mediators of virus entry.";
RL   J. Virol. 72:7064-7074(1998).
RN   [7]
RP   FUNCTION (MICROBIAL INFECTION), AND INTERACTION WITH HERPES SIMPLEX VIRUS
RP   1/HHV-1; HERPES SIMPLEX VIRUS 2/HHV-2 GLYCOPROTEIN D AND PSEUDORABIES VIRUS
RP   GLYCOPROTEIN D.
RX   PubMed=9657005; DOI=10.1006/viro.1998.9218;
RA   Warner M.S., Geraghty R.J., Martinez W.M., Montgomery R.I., Whitbeck J.C.,
RA   Xu R., Eisenberg R.J., Cohen G.H., Spear P.G.;
RT   "A cell surface protein with herpesvirus entry activity (HveB) confers
RT   susceptibility to infection by mutants of herpes simplex virus type 1,
RT   herpes simplex virus type 2, and pseudorabies virus.";
RL   Virology 246:179-189(1998).
RN   [8]
RP   INTERACTION WITH AFADIN.
RX   PubMed=10225955; DOI=10.1083/jcb.145.3.539;
RA   Takahashi K., Nakanishi H., Miyahara M., Mandai K., Satoh K., Satoh A.,
RA   Nishioka H., Aoki J., Nomoto A., Mizoguchi A., Takai Y.;
RT   "Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to
RT   cadherin-based adherens junctions through interaction with Afadin, a PDZ
RT   domain-containing protein.";
RL   J. Cell Biol. 145:539-549(1999).
RN   [9]
RP   INTERACTION WITH NECTIN3 AND NECTIN4.
RX   PubMed=11544254; DOI=10.1074/jbc.m103810200;
RA   Reymond N., Fabre S., Lecocq E., Adelaide J., Dubreuil P., Lopez M.;
RT   "Nectin4/PRR4, a new afadin-associated member of the nectin family that
RT   trans-interacts with nectin1/PRR1 through V domain interaction.";
RL   J. Biol. Chem. 276:43205-43215(2001).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-202.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [11]
RP   INTERACTION WITH INTEGRIN ITGAV/ITGB3.
RX   PubMed=16679515; DOI=10.1074/jbc.m600301200;
RA   Sakamoto Y., Ogita H., Hirota T., Kawakatsu T., Fukuyama T., Yasumi M.,
RA   Kanzaki N., Ozaki M., Takai Y.;
RT   "Interaction of integrin alpha(v)beta3 with nectin. Implication in cross-
RT   talk between cell-matrix and cell-cell junctions.";
RL   J. Biol. Chem. 281:19631-19644(2006).
RN   [12]
RP   GLYCOSYLATION AT ASN-202.
RX   PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B.,
RA   Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L.,
RA   Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core fucosylated
RT   glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-332.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-422 AND SER-434, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 30-335 IN COMPLEX WITH HERPES
RP   SIMPLEX VIRUS GLYCOPROTEIN D, SUBUNIT, AND DISULFIDE BONDS.
RX   PubMed=22146396; DOI=10.1038/ncomms1571;
RA   Zhang N., Yan J., Lu G., Guo Z., Fan Z., Wang J., Shi Y., Qi J., Gao G.F.;
RT   "Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host
RT   cell adhesion.";
RL   Nat. Commun. 2:577-577(2011).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (4.0 ANGSTROMS) OF 31-345 IN COMPLEX WITH HERPES
RP   SIMPLEX VIRUS GLYCOPROTEIN D, FUNCTION, SUBUNIT, MUTAGENESIS OF ASN-82;
RP   SER-84 AND PHE-129, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-72; ASN-139
RP   AND ASN-202.
RX   PubMed=21980294; DOI=10.1371/journal.ppat.1002277;
RA   Di Giovine P., Settembre E.C., Bhargava A.K., Luftig M.A., Lou H.,
RA   Cohen G.H., Eisenberg R.J., Krummenacher C., Carfi A.;
RT   "Structure of herpes simplex virus glycoprotein D bound to the human
RT   receptor nectin-1.";
RL   PLoS Pathog. 7:E1002277-E1002277(2011).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (3.2 ANGSTROMS) OF 31-337, SUBUNIT, GLYCOSYLATION AT
RP   ASN-202, DISULFIDE BONDS, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22902367; DOI=10.1038/nsmb.2366;
RA   Harrison O.J., Vendome J., Brasch J., Jin X., Hong S., Katsamba P.S.,
RA   Ahlsen G., Troyanovsky R.B., Troyanovsky S.M., Honig B., Shapiro L.;
RT   "Nectin ectodomain structures reveal a canonical adhesive interface.";
RL   Nat. Struct. Mol. Biol. 19:906-915(2012).
CC   -!- FUNCTION: Promotes cell-cell contacts by forming homophilic or
CC       heterophilic trans-dimers. Heterophilic interactions have been detected
CC       between NECTIN1 and NECTIN3 and between NECTIN1 and NECTIN4. Has some
CC       neurite outgrowth-promoting activity. {ECO:0000269|PubMed:21980294}.
CC   -!- FUNCTION: (Microbial infection) Acts as a receptor for herpes simplex
CC       virus 1/HHV-1, herpes simplex virus 2/HHV-2, and pseudorabies
CC       virus/PRV. {ECO:0000269|PubMed:7721102, ECO:0000269|PubMed:9657005}.
CC   -!- SUBUNIT: Interacts (via Ig-like C2-type domain 2) with FGFR1, FGFR2 and
CC       FGFR3 (By similarity). Cis- and trans-homodimer. Can form trans-
CC       heterodimers with NECTIN3 and with NECTIN4. Interaction between NECTIN1
CC       and NECTIN3 on the pre- and postsynaptic sites, respectively, initiates
CC       the formation of puncta adherentia junctions between axons and
CC       dendrites. Interacts (via cytoplasmic domain) with AFDN (via PDZ
CC       domain); this interaction recruits NECTIN1 to cadherin-based adherens
CC       junctions and provides a connection with the actin cytoskeleton.
CC       Interacts with integrin alphaV/beta3. {ECO:0000250,
CC       ECO:0000269|PubMed:10225955, ECO:0000269|PubMed:11544254,
CC       ECO:0000269|PubMed:16679515, ECO:0000269|PubMed:22902367}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with herpes simplex virus
CC       1/HHV-1, herpes simplex virus 2/HHV-2, and pseudorabies virus/PRV
CC       envelope glycoprotein D (PubMed:21980294, PubMed:22146396,
CC       PubMed:9696799, PubMed:9657005). {ECO:0000269|PubMed:21980294,
CC       ECO:0000269|PubMed:22146396, ECO:0000269|PubMed:9657005,
CC       ECO:0000269|PubMed:9696799}.
CC   -!- INTERACTION:
CC       Q15223; Q92520: FAM3C; NbExp=3; IntAct=EBI-1771314, EBI-2876774;
CC       Q15223; Q15223: NECTIN1; NbExp=4; IntAct=EBI-1771314, EBI-1771314;
CC       Q15223; Q9NQS3: NECTIN3; NbExp=2; IntAct=EBI-1771314, EBI-2826725;
CC       Q15223; Q9NQS3-1: NECTIN3; NbExp=3; IntAct=EBI-1771314, EBI-16007706;
CC       Q15223; Q96NY8: NECTIN4; NbExp=5; IntAct=EBI-1771314, EBI-4314784;
CC       Q15223; O00560: SDCBP; NbExp=8; IntAct=EBI-1771314, EBI-727004;
CC   -!- SUBCELLULAR LOCATION: [Isoform Alpha]: Cell membrane; Single-pass type
CC       I membrane protein. Presynaptic cell membrane {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform Delta]: Cell membrane; Single-pass type
CC       I membrane protein.
CC   -!- SUBCELLULAR LOCATION: [Isoform Gamma]: Secreted.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=Delta;
CC         IsoId=Q15223-1; Sequence=Displayed;
CC       Name=Alpha;
CC         IsoId=Q15223-2; Sequence=VSP_002626, VSP_002627;
CC       Name=Gamma;
CC         IsoId=Q15223-3; Sequence=VSP_002624, VSP_002625;
CC   -!- DOMAIN: Ig-like C2-type 2 mediates neurite outgrowth through binding,
CC       induction of phosphorylation, and activation of FGFR. {ECO:0000250}.
CC   -!- DISEASE: Ectodermal dysplasia, Margarita Island type (EDMI)
CC       [MIM:225060]: An autosomal recessive form of ectodermal dysplasia, a
CC       heterogeneous group of disorders due to abnormal development of two or
CC       more ectodermal structures. It is a syndrome characterized by the
CC       association of cleft lip/palate, ectodermal dysplasia (sparse short and
CC       dry scalp hair, sparse eyebrows and eyelashes), and partial syndactyly
CC       of the fingers and/or toes. Two thirds of the patients do not manifest
CC       oral cleft but present with abnormal teeth and nails.
CC       {ECO:0000269|PubMed:10932188}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Non-syndromic orofacial cleft 7 (OFC7) [MIM:225060]: A birth
CC       defect consisting of cleft lips with or without cleft palate. Cleft
CC       lips are associated with cleft palate in two-third of cases. A cleft
CC       lip can occur on one or both sides and range in severity from a simple
CC       notch in the upper lip to a complete opening in the lip extending into
CC       the floor of the nostril and involving the upper gum.
CC       {ECO:0000269|PubMed:10932188}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the nectin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAA53980.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X76400; CAA53980.2; ALT_INIT; mRNA.
DR   EMBL; AF060231; AAC23798.1; -; mRNA.
DR   EMBL; AY029539; AAK33124.1; -; mRNA.
DR   EMBL; BC104948; AAI04949.1; -; mRNA.
DR   EMBL; BC113471; AAI13472.1; -; mRNA.
DR   EMBL; AF252867; AAG16648.1; -; Genomic_DNA.
DR   EMBL; AF196768; AAG16648.1; JOINED; Genomic_DNA.
DR   EMBL; AF196769; AAG16648.1; JOINED; Genomic_DNA.
DR   EMBL; AF196770; AAG16648.1; JOINED; Genomic_DNA.
DR   EMBL; AF196771; AAG16648.1; JOINED; Genomic_DNA.
DR   EMBL; AF196774; AAG16649.1; -; Genomic_DNA.
DR   EMBL; AF196768; AAG16649.1; JOINED; Genomic_DNA.
DR   EMBL; AF196769; AAG16649.1; JOINED; Genomic_DNA.
DR   EMBL; AF196770; AAG16649.1; JOINED; Genomic_DNA.
DR   EMBL; AF196771; AAG16649.1; JOINED; Genomic_DNA.
DR   EMBL; AF196772; AAG16649.1; JOINED; Genomic_DNA.
DR   EMBL; AF196773; AAG16649.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS8425.1; -. [Q15223-2]
DR   CCDS; CCDS8426.1; -. [Q15223-1]
DR   CCDS; CCDS8427.1; -. [Q15223-3]
DR   PIR; JC4024; JC4024.
DR   RefSeq; NP_002846.3; NM_002855.4. [Q15223-1]
DR   RefSeq; NP_976030.1; NM_203285.1. [Q15223-2]
DR   RefSeq; NP_976031.1; NM_203286.1. [Q15223-3]
DR   PDB; 3ALP; X-ray; 2.80 A; A/B=30-335.
DR   PDB; 3SKU; X-ray; 4.00 A; D/E/F=31-345.
DR   PDB; 3U82; X-ray; 3.16 A; B=30-335.
DR   PDB; 3U83; X-ray; 2.50 A; A=30-335.
DR   PDB; 4FMF; X-ray; 3.20 A; A/B/C/D=31-337.
DR   PDB; 4MYW; X-ray; 3.19 A; B/D=30-335.
DR   PDBsum; 3ALP; -.
DR   PDBsum; 3SKU; -.
DR   PDBsum; 3U82; -.
DR   PDBsum; 3U83; -.
DR   PDBsum; 4FMF; -.
DR   PDBsum; 4MYW; -.
DR   AlphaFoldDB; Q15223; -.
DR   SMR; Q15223; -.
DR   BioGRID; 111776; 16.
DR   CORUM; Q15223; -.
DR   DIP; DIP-40302N; -.
DR   IntAct; Q15223; 17.
DR   MINT; Q15223; -.
DR   STRING; 9606.ENSP00000264025; -.
DR   GlyConnect; 1536; 4 N-Linked glycans (3 sites).
DR   GlyGen; Q15223; 10 sites, 3 N-linked glycans (3 sites), 2 O-linked glycans (1 site).
DR   iPTMnet; Q15223; -.
DR   PhosphoSitePlus; Q15223; -.
DR   BioMuta; NECTIN1; -.
DR   DMDM; 18202503; -.
DR   EPD; Q15223; -.
DR   jPOST; Q15223; -.
DR   MassIVE; Q15223; -.
DR   MaxQB; Q15223; -.
DR   PaxDb; Q15223; -.
DR   PeptideAtlas; Q15223; -.
DR   PRIDE; Q15223; -.
DR   ProteomicsDB; 60490; -. [Q15223-1]
DR   ProteomicsDB; 60491; -. [Q15223-2]
DR   ProteomicsDB; 60492; -. [Q15223-3]
DR   Antibodypedia; 4247; 439 antibodies from 38 providers.
DR   DNASU; 5818; -.
DR   Ensembl; ENST00000264025.8; ENSP00000264025.3; ENSG00000110400.11. [Q15223-1]
DR   Ensembl; ENST00000340882.2; ENSP00000345289.2; ENSG00000110400.11. [Q15223-3]
DR   Ensembl; ENST00000341398.6; ENSP00000344974.2; ENSG00000110400.11. [Q15223-2]
DR   GeneID; 5818; -.
DR   KEGG; hsa:5818; -.
DR   MANE-Select; ENST00000264025.8; ENSP00000264025.3; NM_002855.5; NP_002846.3.
DR   UCSC; uc001pwu.2; human. [Q15223-1]
DR   CTD; 5818; -.
DR   DisGeNET; 5818; -.
DR   GeneCards; NECTIN1; -.
DR   HGNC; HGNC:9706; NECTIN1.
DR   HPA; ENSG00000110400; Tissue enhanced (esophagus, skin).
DR   MalaCards; NECTIN1; -.
DR   MIM; 225060; phenotype.
DR   MIM; 600644; gene.
DR   neXtProt; NX_Q15223; -.
DR   OpenTargets; ENSG00000110400; -.
DR   Orphanet; 141291; Cleft lip and alveolus.
DR   Orphanet; 199306; Cleft lip/palate.
DR   Orphanet; 3253; Cleft lip/palate-ectodermal dysplasia syndrome.
DR   Orphanet; 199302; Isolated cleft lip.
DR   PharmGKB; PA34051; -.
DR   VEuPathDB; HostDB:ENSG00000110400; -.
DR   eggNOG; ENOG502QVRJ; Eukaryota.
DR   GeneTree; ENSGT00940000156933; -.
DR   HOGENOM; CLU_029618_1_2_1; -.
DR   InParanoid; Q15223; -.
DR   OMA; TTEPGEC; -.
DR   OrthoDB; 509401at2759; -.
DR   PhylomeDB; Q15223; -.
DR   TreeFam; TF331051; -.
DR   PathwayCommons; Q15223; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   Reactome; R-HSA-420597; Nectin/Necl trans heterodimerization.
DR   SignaLink; Q15223; -.
DR   BioGRID-ORCS; 5818; 10 hits in 1068 CRISPR screens.
DR   ChiTaRS; NECTIN1; human.
DR   EvolutionaryTrace; Q15223; -.
DR   GeneWiki; PVRL1; -.
DR   GenomeRNAi; 5818; -.
DR   Pharos; Q15223; Tbio.
DR   PRO; PR:Q15223; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q15223; protein.
DR   Bgee; ENSG00000110400; Expressed in lower esophagus mucosa and 175 other tissues.
DR   Genevisible; Q15223; HS.
DR   GO; GO:0005912; C:adherens junction; IDA:BHF-UCL.
DR   GO; GO:0043296; C:apical junction complex; IEA:Ensembl.
DR   GO; GO:0044291; C:cell-cell contact zone; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0032584; C:growth cone membrane; IEA:Ensembl.
DR   GO; GO:0098686; C:hippocampal mossy fiber to CA3 synapse; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0099059; C:integral component of presynaptic active zone membrane; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030246; F:carbohydrate binding; IEA:Ensembl.
DR   GO; GO:0050839; F:cell adhesion molecule binding; IPI:BHF-UCL.
DR   GO; GO:0015026; F:coreceptor activity; TAS:ProtInc.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; ISS:HGNC-UCL.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0046790; F:virion binding; IEA:Ensembl.
DR   GO; GO:0001618; F:virus receptor activity; IEA:UniProtKB-KW.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0007155; P:cell adhesion; NAS:UniProtKB.
DR   GO; GO:0098609; P:cell-cell adhesion; NAS:UniProtKB.
DR   GO; GO:0002934; P:desmosome organization; IEA:Ensembl.
DR   GO; GO:0070166; P:enamel mineralization; IEA:Ensembl.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:HGNC-UCL.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; ISS:HGNC-UCL.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0006826; P:iron ion transport; IEA:Ensembl.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; IEA:Ensembl.
DR   GO; GO:1902414; P:protein localization to cell junction; IBA:GO_Central.
DR   GO; GO:0051963; P:regulation of synapse assembly; IEA:Ensembl.
DR   GO; GO:0060041; P:retina development in camera-type eye; IEA:Ensembl.
DR   GO; GO:0046718; P:viral entry into host cell; NAS:UniProtKB.
DR   GO; GO:0019062; P:virion attachment to host cell; IEA:InterPro.
DR   CDD; cd05886; Ig1_Nectin-1_like; 1.
DR   CDD; cd05890; Ig2_Nectin-1_like; 1.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   InterPro; IPR041849; Nectin-1_Ig1.
DR   InterPro; IPR041850; Nectin-1_Ig2.
DR   InterPro; IPR033314; Nectin1.
DR   PANTHER; PTHR23277:SF69; PTHR23277:SF69; 1.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF13895; Ig_2; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 2.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell adhesion; Cell membrane;
KW   Cell projection; Disulfide bond; Ectodermal dysplasia; Glycoprotein;
KW   Host cell receptor for virus entry; Host-virus interaction;
KW   Immunoglobulin domain; Membrane; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Secreted; Signal; Synapse; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..30
FT                   /evidence="ECO:0000255"
FT   CHAIN           31..517
FT                   /note="Nectin-1"
FT                   /id="PRO_0000015133"
FT   TOPO_DOM        31..355
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        356..376
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        377..517
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          31..141
FT                   /note="Ig-like V-type"
FT   DOMAIN          149..238
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          247..334
FT                   /note="Ig-like C2-type 2"
FT   REGION          282..299
FT                   /note="Interaction with FGFR"
FT                   /evidence="ECO:0000250"
FT   REGION          399..488
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        419..434
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        446..480
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         422
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         434
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692"
FT   MOD_RES         435
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JKF6"
FT   MOD_RES         436
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JKF6"
FT   MOD_RES         511
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JKF6"
FT   CARBOHYD        36
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        72
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21980294"
FT   CARBOHYD        139
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21980294"
FT   CARBOHYD        202
FT                   /note="N-linked (GlcNAc...) (complex) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:21980294,
FT                   ECO:0000269|PubMed:22902367"
FT   CARBOHYD        286
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        297
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        307
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        332
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19349973"
FT   DISULFID        51..124
FT                   /evidence="ECO:0000269|PubMed:22146396,
FT                   ECO:0000269|PubMed:22902367, ECO:0000305|PubMed:21980294"
FT   DISULFID        172..226
FT                   /evidence="ECO:0000269|PubMed:22146396,
FT                   ECO:0000269|PubMed:22902367, ECO:0000305|PubMed:21980294"
FT   DISULFID        269..316
FT                   /evidence="ECO:0000269|PubMed:22146396,
FT                   ECO:0000269|PubMed:22902367, ECO:0000305|PubMed:21980294"
FT   VAR_SEQ         335..352
FT                   /note="EFPYTPSPPEHGRRAGPV -> AFCQLIYPGKGRTRARMF (in isoform
FT                   Gamma)"
FT                   /evidence="ECO:0000303|PubMed:11356977"
FT                   /id="VSP_002624"
FT   VAR_SEQ         336..458
FT                   /note="FPYTPSPPEHGRRAGPVPTAIIGGVAGSILLVLIVVGGIVVALRRRRHTFKG
FT                   DYSTKKHVYGNGYSKAGIPQHHPPMAQNLQYPDDSDDEKKAGPLGGSSYEEEEEEEEGG
FT                   GGGERKVGGPHP -> KPRPQRGLGSAARLLAGTVAVFLILVAVLTVFFLYNRQQKSPP
FT                   ETDGAGTDQPLSQKPEPSPSRQSSLVPEDIQVVHLDPGRQQQQEEEDLQKLSLQPPYYD
FT                   LGVSPSYHPSVRTTEPRGECP (in isoform Alpha)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_002626"
FT   VAR_SEQ         353..517
FT                   /note="Missing (in isoform Gamma)"
FT                   /evidence="ECO:0000303|PubMed:11356977"
FT                   /id="VSP_002625"
FT   VAR_SEQ         459..517
FT                   /note="Missing (in isoform Alpha)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_002627"
FT   MUTAGEN         82
FT                   /note="N->Y: Impairs interaction with herpes simplex
FT                   glycoprotein D. Decreases susceptibility to infection by
FT                   herpes simplex virus."
FT                   /evidence="ECO:0000269|PubMed:21980294"
FT   MUTAGEN         84
FT                   /note="S->Y: Impairs interaction with herpes simplex
FT                   glycoprotein D. Decreases susceptibility to infection by
FT                   herpes simplex virus."
FT                   /evidence="ECO:0000269|PubMed:21980294"
FT   MUTAGEN         129
FT                   /note="F->A,S: Impairs interaction with herpes simplex
FT                   glycoprotein D. Decreases susceptibility to infection by
FT                   herpes simplex virus."
FT                   /evidence="ECO:0000269|PubMed:21980294"
FT   STRAND          37..42
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          47..49
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          61..71
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          74..82
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   TURN            83..85
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          86..89
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   TURN            94..96
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          97..101
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          103..106
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   HELIX           116..118
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          120..129
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          132..144
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          147..152
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          157..159
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          167..179
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          182..189
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          192..199
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          205..213
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   HELIX           217..219
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          223..230
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          233..240
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          243..252
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          265..275
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          279..284
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          293..296
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          299..302
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   HELIX           308..310
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          312..320
FT                   /evidence="ECO:0007829|PDB:3U83"
FT   STRAND          323..331
FT                   /evidence="ECO:0007829|PDB:3U83"
SQ   SEQUENCE   517 AA;  57158 MW;  DF34C8AEC893EE6D CRC64;
     MARMGLAGAA GRWWGLALGL TAFFLPGVHS QVVQVNDSMY GFIGTDVVLH CSFANPLPSV
     KITQVTWQKS TNGSKQNVAI YNPSMGVSVL APYRERVEFL RPSFTDGTIR LSRLELEDEG
     VYICEFATFP TGNRESQLNL TVMAKPTNWI EGTQAVLRAK KGQDDKVLVA TCTSANGKPP
     SVVSWETRLK GEAEYQEIRN PNGTVTVISR YRLVPSREAH QQSLACIVNY HMDRFKESLT
     LNVQYEPEVT IEGFDGNWYL QRMDVKLTCK ADANPPATEY HWTTLNGSLP KGVEAQNRTL
     FFKGPINYSL AGTYICEATN PIGTRSGQVE VNITEFPYTP SPPEHGRRAG PVPTAIIGGV
     AGSILLVLIV VGGIVVALRR RRHTFKGDYS TKKHVYGNGY SKAGIPQHHP PMAQNLQYPD
     DSDDEKKAGP LGGSSYEEEE EEEEGGGGGE RKVGGPHPKY DEDAKRPYFT VDEAEARQDG
     YGDRTLGYQY DPEQLDLAEN MVSQNDGSFI SKKEWYV
//
